View in EDS

Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis.

Saved in:
Bibliographic Details
Title: Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis.
Authors: Sandborn WJ; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA. sandborn.william@mayo.edu, Korzenik J, Lashner B, Leighton JA, Mahadevan U, Marion JF, Safdi M, Sninsky CA, Patel RM, Friedenberg KA, Dunnmon P, Ramsey D, Kane S
Source: Gastroenterology [Gastroenterology] 2010 Apr; Vol. 138 (4), pp. 1286-96, 1296.e1-3. Date of Electronic Publication: 2010 Jan 11.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0374630 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0012 (Electronic) Linking ISSN: 00165085 NLM ISO Abbreviation: Gastroenterology Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 20064514
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sandborn+WJ%22">Sandborn WJ</searchLink>; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA. sandborn.william@mayo.edu<br /><searchLink fieldCode="AU" term="%22Korzenik+J%22">Korzenik J</searchLink><br /><searchLink fieldCode="AU" term="%22Lashner+B%22">Lashner B</searchLink><br /><searchLink fieldCode="AU" term="%22Leighton+JA%22">Leighton JA</searchLink><br /><searchLink fieldCode="AU" term="%22Mahadevan+U%22">Mahadevan U</searchLink><br /><searchLink fieldCode="AU" term="%22Marion+JF%22">Marion JF</searchLink><br /><searchLink fieldCode="AU" term="%22Safdi+M%22">Safdi M</searchLink><br /><searchLink fieldCode="AU" term="%22Sninsky+CA%22">Sninsky CA</searchLink><br /><searchLink fieldCode="AU" term="%22Patel+RM%22">Patel RM</searchLink><br /><searchLink fieldCode="AU" term="%22Friedenberg+KA%22">Friedenberg KA</searchLink><br /><searchLink fieldCode="AU" term="%22Dunnmon+P%22">Dunnmon P</searchLink><br /><searchLink fieldCode="AU" term="%22Ramsey+D%22">Ramsey D</searchLink><br /><searchLink fieldCode="AU" term="%22Kane+S%22">Kane S</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220374630%22">Gastroenterology</searchLink> [Gastroenterology] 2010 Apr; Vol. 138 (4), pp. 1286-96, 1296.e1-3. <i>Date of Electronic Publication: </i>2010 Jan 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22W%2EB%2E+Saunders%22">W.B. Saunders </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0374630 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0012 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200165085%22">00165085 </searchLink><i>NLM ISO Abbreviation: </i>Gastroenterology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=20064514
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1053/j.gastro.2009.12.054
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1286
    Titles:
      – TitleFull: Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sandborn WJ
      – PersonEntity:
          Name:
            NameFull: Korzenik J
      – PersonEntity:
          Name:
            NameFull: Lashner B
      – PersonEntity:
          Name:
            NameFull: Leighton JA
      – PersonEntity:
          Name:
            NameFull: Mahadevan U
      – PersonEntity:
          Name:
            NameFull: Marion JF
      – PersonEntity:
          Name:
            NameFull: Safdi M
      – PersonEntity:
          Name:
            NameFull: Sninsky CA
      – PersonEntity:
          Name:
            NameFull: Patel RM
      – PersonEntity:
          Name:
            NameFull: Friedenberg KA
      – PersonEntity:
          Name:
            NameFull: Dunnmon P
      – PersonEntity:
          Name:
            NameFull: Ramsey D
      – PersonEntity:
          Name:
            NameFull: Kane S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2010 Apr
              Type: published
              Y: 2010
          Identifiers:
            – Type: issn-electronic
              Value: 1528-0012
          Numbering:
            – Type: volume
              Value: 138
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Gastroenterology
              Type: main
ResultId 1